Novel pyridine derivative and pyrimidine derivative (2)

Details for Australian Patent Application No. 2005217328 (hide)

Owner Eisai R and D Management Co., Ltd.

Inventors Funasaka, Setsuo; Matsushima, Tomohiro; Takahashi, Keiko; Obaishi, Hiroshi

Agent Davies Collison Cave

Pub. Number AU-B-2005217328

PCT Pub. Number WO2005/082855

Priority 2004-054451 27.02.04 JP; 2004-370801 22.12.04 JP

Filing date 25 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 4 October 2007

International Classifications

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/082855 Priority application(s): WO2005/082855

18 January 2007 Assignment before Grant

  Eisai Co., Ltd. The application has been assigned to Eisai R and D Management Co., Ltd.

4 October 2007 Application Accepted

  Published as AU-B-2005217328

31 January 2008 Standard Patent Sealed

23 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005217335-Coumarin derivative and use thereof

2005217325-Novel pyridine derivative and pyrimidine derivative (1)